ProfileGDS5678 / 1426165_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 16% 28% 28% 54% 26% 27% 15% 24% 34% 28% 53% 36% 26% 43% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4223616
GSM967853U87-EV human glioblastoma xenograft - Control 22.6358628
GSM967854U87-EV human glioblastoma xenograft - Control 32.6379528
GSM967855U87-EV human glioblastoma xenograft - Control 43.2821254
GSM967856U87-EV human glioblastoma xenograft - Control 52.5537226
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.6816927
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4083215
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.5512724
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.7621234
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.6230428
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.276653
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.7791936
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.6035326
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.9944743